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Ten genome-wide scans have been conducted over the past few years in the search for psoriasis susceptibility
genes, but only one potential susceptibility region has been consistently replicated. A meta-analysis using the
genome-search meta-analysis method was undertaken combining the results of six of these psoriasis genome-
wide studies. The results of this analysis revealed linkage to the major histocompatibility complex on chromosome
6p21 that includes the PSORS1 locus. In addition, linkage was also recorded to a region on chromosome 4q28–q31
previously identiﬁed only in a Chinese Hans population. Both these regions were statistically signiﬁcant even after
correction for multiple testing. A possible reason for the erratic replication of ﬁndings could be the large effect of
the PSORS1 locus (6p21) masking the effect of other loci involved in psoriasis. To overcome this problem, we
suggest that future studies condition on the effect of the PSORS1 locus.
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Psoriasis is a chronic inflammatory dermatosis affecting
approximately 2%–5% of the Caucasian population (Nevitt
and Hutchinson, 1996) and 0.1%–0.3% in the Far East
(Simons, 1949) and China (Yui Yip, 1984). Familial studies
have suggested a multifactorial mode of inheritance, and
the view that psoriasis is a disease involving gene–gene and
gene–environment interactions is widely held (Elder et al,
2001). The genes involved in psoriasis are believed to
interact with several environmental triggers including
streptococcal infection, stress, smoking, and physical
trauma (Swanbeck et al, 1994; Tagami, 1997).
Several genome-wide scans have been conducted
over the last few years in the search for genes predisposing
to familial psoriasis (Tomfohrde et al, 1994; Matthews
et al, 1996; Nair et al, 1997; Trembath et al, 1997;
Capon et al, 1999; Samuelsson et al, 1999; Lee et al,
2000; Veal et al, 2001; Zhang et al, 2002; Asumalahti et al,
2003). These studies have confirmed previous findings and
also indicated novel candidate regions. Eight loci desig-
nated PSORS1-7 and PSORS9 with a further 11 undesig-
nated loci have been identified as potential psoriasis
susceptibility loci (Table I). These 19 loci are located on 15
different chromosomes and of these regions only the locus
on the short arm of chromosome 6 within the major
histocompatibility complex (MHC) is consistently implicated
in psoriasis (see Table I). Of the other regions, only three on
chromosomes 17q25, 19p13, and 20p have been impli-
cated by more than one genome-wide study. Several
regions have been replicated in other studies focussing on
specific regions. For instance, chromosomes 1q, 2p, 4q13,
and 14q have been implicated by Bhalerao and Bowcock
(1998), chromosome 3q by Enlund et al (1999a), and
chromosome 17q25 by Enlund et al (1999b). Thus, although
these genome-wide scans have proved to be useful in
identifying genetic regions that may potentially harbor
disease susceptibility genes, replication of significant
results and a systematic method of reviewing these results
has not been forthcoming.
The best way to combine and analyze the results of the
genome-wide studies that have been conducted on familial
psoriasis is by conducting a meta-analysis. A meta-analysis
is a statistical procedure by which results from individual
studies are combined to produce a test of a particular
hypothesis. In conducting a meta-analysis, we may confirm
previous findings or find novel susceptibility loci where the
genetic effect is too small to be detected in any single study.
Gu et al (1998) developed a meta-analysis of genome-wide
studies that pools the results of sib-pair studies. The major
drawback of this method is that the same markers must be
used in each study and this is rarely the case. Wise et al
(1999) have developed a more generally applicable genome
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search meta-analysis (GSMA) method utilizing published
results from genome-wide studies to identify genetic regions
that show evidence of linkage across studies. The GSMA
method has been designed to be robust across study
designs, and does not require the use of a common set of
markers across the studies. Only the marker positions and
their p-values or LOD scores are required for this analysis. It
is for these reasons that we felt the GSMA method was
ideally suited to analyzing the psoriasis genome screens.
Results
The results of the meta-analysis carried out on the six
genome-wide studies for which results were available can
be seen in Fig 1, with the highest-ranking bins (po0.05)
listed in Table II. A total of five bins lay above the 95%
threshold, with three of these being above the 99%
threshold. After correction for multiple testing (either by
the Bonferroni method or by a permutation method), only
the two highest of these were significant. The highest-
ranking bin (position 33—66 cM on chromosome 6)
corresponds to the PSORS1 susceptibility locus within the
MHC reported by 6 of the studies (p¼3.37  106 after
correction). The bin adjacent to this (position 66–99 cM on
chromosome 6) was ranked third (p¼0.40 after correction).
The second highest ranked bin (position 132–165 cM on
chromosome 4) corresponds to a novel candidate region
previously reported only by Zhang et al (2002) in the
Chinese Hans population (p¼0.02 after correction).
When the data were re-analyzed without the Chinese
Hans study (2002), six bins were above the 95% threshold
(Table II), with two above the 99% threshold. The three top-
ranking bins were the same as in the previous analysis. Only
the highest ranked bin remained significant once multiple
testing was accounted for. We tested the robustness of our
results to the absence of each of the Caucasian studies by
repeating the meta-analysis five times excluding a different
Caucasian study each time. In each case, the top three
ranked regions remained the same as in the full meta-
analysis, except one where the third ranked region dropped
to fourth place.
Discussion
A meta-analysis was conducted using data from six
previously published genome-wide scans. After correction
for multiple testing, two regions on chromosomes 6p21 and
4q31 were found to be significant (po0.05). The MHC
region on chromosome 6p21 was previously reported in all
six of the studies used here but the genetic region on
chromosome 4q28–q31 was only reported as significant by
Zhang et al (2002). It is possible that including the results
from the Chinese Hans study (2002) in this meta-analysis
may cause problems due to genetic heterogeneity between
populations. But the top three bins were the same even
when the data were re-analyzed without the Zhang et al
(2002) study. The region reported by Zhang et al (2002)
(chromosome 4q28–q31) had a nominal p-value of
Table I. List of published putative psoriasis susceptibility loci
from genome-wide studies (updated and adapted from
Capon et al (2002))
Location
Locus name
(if applicable) Linkage reports
1p PSORS7 Veal et al (2001)
1q PSORS4 Capon et al (1999)
2p Veal et al (2001)
2q Trembath et al (1997)
3q PSORS5 Samuelsson et al (1999)
4q13 Samuelsson et al (1999)
4q31 PSORS9 Zhang et al (2002)
4q34 PSORS3 Matthews et al (1996)
6p21.3 PSORS1 Nair et al (1997);
Trembath et al (1997);
Samuelsson et al (1999);
Veal et al (2001);
Zhang et al (2002)
7 Veal et al (2001)
8q Trembath et al (1997)
9q33 Zhang et al (2002)
14q Veal et al (2001)
15 Samuelsson et al (1999)
16q Nair et al (1997)
17q25 PSORS2 Tomfohrde et al (1994);
Nair et al (1997);
Samuelsson et al (1999)
18p11 Asumalahti et al (2003)
19p13 PSORS6 Lee et al (2000);
Veal et al (2001)
20p Nair et al (1997);
Trembath et al (1997)
Figure1
Genome search meta-analysis (GSMA) results from six psoriasis
genome-wide scans. The summed ranks (vertical axis) are plotted
against the bin location by chromosome (horizontal axis). The 95th and
99th percentiles for the distribution of summed ranks are also shown.
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1.69  103 even without the inclusion of their results,
which, although not significant after a Bonferroni correction,
suggests strong evidence for association between this
region and psoriasis susceptibility in the Caucasian as well
as the Chinese Hans population.
Although 19 loci on 15 chromosomes have been
published thus far as candidate regions, our meta-analysis
only provided significant evidence for two chromosomal
regions. The third-ranking bin on chromosome 6 (position
66–99 cM) is adjacent to the top-ranking bin and corre-
sponds to the centromeric region of chromosome 6 cover-
ing 6p12 to 6q15. The evidence for this region indicates
either the existence of a second susceptibility locus within
this region as suggested by Capon et al (2003) or that the
effect of PSORS1 can be detected in the adjacent bin.
In Table III, we have listed the bins for the three most
significant regions and have given for each of the studies
the name of the most significant marker (if available), its
position, and its p-value.
Those loci that have been identified as potentially
involved in psoriasis susceptibility in only one or two studies
but are not picked up in our meta-analysis may be false
positives, be peculiar to the population used or other
studies may just lack the power to detect them. A large
collaborative study was recently carried out by The
International Psoriasis Genetics Consortium (2003), which
used a very large sample size to overcome the problem of
low power. This study provided unequivocal evidence for
the major role of a gene or genes within the MHC but
demonstrated no compelling support for non-MHC loci.
It is also of note that the 19p13 locus was identified in
two of the studies (Lee et al, 2000; Veal et al, 2001) and
was recently further corroborated by an association scan
involving 210 trios with early-onset psoriasis from Northern
Germany (Hensen et al, 2003). It is therefore probable that
the PSORS6 locus represents a founder mutation in Anglo-
Saxons/North-Germans that occurred after the migration
out of Africa.
Another possible reason for the lack of replication of
some results could be the large effect of the PSORS1 locus
masking the other loci involved in psoriasis. Because of
this potentially strong effect, we would suggest that future
studies condition on the effect of the PSORS1 locus when
conducting analysis. This could be done by stratifying
samples into those segregating for the known disease locus
(6p21) and those that do not. It is also possible to conduct a
conditional analysis using methods such as those devel-
oped by Dudbridge (2002, 2003), and Cordell et al (1995,
2000). Using this type of method could lead to an even
greater understanding of the genetic etiology of psoriasis.
In conclusion, our meta-analysis of six published
psoriasis genome-wide scans has provided further support
Table II. Bins with p-values o0.05 from our meta-analysis of all six psoriasis genome-wide scans and the ﬁve
Caucasian psoriasis genome-wide scans
Rank
All six studies Caucasian studies only
Chromosomal position p-value Chromosomal position p-value
1 6p21 (33–66 cM) 3.06  108 (o0.00001) 6p21 (33–66 cM) 9.62  107 (o0.00001)
2 4q31 (132–165 cM) 2.47  104(0.0117) 4q31 (132–165 cM) 1.69  103 (0.13977)
3 6p12–q15 (66–99 cM) 4.64  103 (0.34987) 6p12–q15 (66–99 cM) 0.019 (0.86587)
4 13q (66–99 cM) 0.038 (0.95632) 16q23–q24 (99–end) 0.039 (0.9781)
5 16q23–q24 (99–end) 0.049 (0.99134) 10q26 (165–end) 0.044 (0.99013)
6 10q26 (165–end) 0.054 (0.99934) 17p12–p13 (0–33 cM) 0.048 (0.99523)
Nominal p-values followed in brackets by p-values estimated by permutation to account for multiple testing.
Table III. Signiﬁcant psoriasis susceptibility regions as revealed by our meta-analysis with the position, name (if known),
and p-value of the most signiﬁcant marker found within that bin in each study
Trembath
et al (1997)
Nair et al
(1997)
Samuelsson
et al (1999)
Lee et al
(2000)
Veal et al
(2001)
Zhang
et al (2002)
Chromosome 4 bin
132–165 cM
157.9 cM
(D4S413)
153.6 cM
(D4S1548)
145 cM 160.9 cM (D4S393) 143.1 cM
(D4S1565)
159.1 cM
(D4S2997)
p¼0.029 p¼ 0.0297 p¼0.077 p¼0.0787 p¼ 0.07 p¼ 0.0066
Chromosome 6 bin
33–66 cM
44.9 cM
(D6S273)
49.8 cM (D6S291) 49 cM (D6S1019) 34.3 cM (D6S422) 44.9 cM (D6S273) 48.3 cM
(D6S1645)
p¼0.00071 p¼ 0.0217 p¼0.019 p¼0.0265 p¼ 0.00012 p¼ 0.00046
Chromosome 6 bin
66–99 cM
90 cM
(D6S286)
66.4 cM (D6S282) 77 cM 88.6 cM (D6S286) 74.1 cM (D6S272) 90 cM (D6S460)
p¼0.084 p¼ 0.1496 p¼0.032 p¼0.2182 p¼ 0.0000002 p¼ 0.0056
The position in cM for each marker is the distance from the top of the chromosome linkage group (Dib et al, 1996; Broman et al, 1998).
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for the susceptibility locus on chromosome 6p21, and
suggests that the susceptibility locus on chromosome 4q31
(Zhang et al, 2002) is important in the Caucasian as well as
the Chinese Hans population.
Materials and Methods
A meta-analysis using the GSMA method (Wise et al, 1999) was
conducted with the aim of identifying loci showing significant
evidence of affecting psoriasis susceptibility across several
studies. We were able to obtain the full results from five of the
studies (Nair et al, 1997; Trembath et al, 1997; Samuelsson et al,
1999; Lee et al, 2000; Veal et al, 2001). Unfortunately, data were not
available from either the Capon et al (1999) study or the Zhang et al
(2002) study. The Capon et al (1999) study published the results for
only four markers on chromosome 1q21, so this study could not be
included in our analysis. But the Zhang et al (2002) study could
be included in our analysis as we were able to assign ranks to
the eight most significant bins reported in the paper, with the
remaining bins being assigned equal rank as described in Wise
et al (1999). The genome-wide studies conducted by Tomfohrde
et al (1994), Matthews et al (1996), and Asumalahti et al (2003)
were not included in our analysis. These studies involved only a
small number of families (8, 1, and 9, respectively), and we felt
that the problems involved in accounting for differences in sample
size between studies outweighed the information to be gained
from them. Furthermore, Asumalahti et al (2003) selected only
PSORS1-negative families for their genome-wide scan, which
would have biased the meta-analysis. The studies used in our
meta-analysis differed in some aspects of design such as the
number of families within each study, the number of markers, and
the disease criteria used. Five of the six studies used in our meta-
analysis are of a similar ethnic background (Caucasian), whereas
Zhang et al (2002) used the Chinese Hans population in their
study. The main characteristics of the six studies are summarized
in Table IV.
The GSMA method (Wise et al, 1999) uses a non-parametric
ranking method to identify genetic regions with consistently
increased sharing statistics. The genome is divided into distinct
regions (bins) and the evidence for linkage within each bin is
evaluated across the studies. We initially applied the GSMA
method to the six psoriasis genome-wide studies (Nair et al,
1997; Trembath et al, 1997; Samuelsson et al, 1999; Lee et al,
2000; Veal et al, 2001; Zhang et al, 2002), with the assumption that
the results from each genome search contributed equally to the
meta-analysis. The genome was divided into 110 bins of
approximately equal size in each of the six studies. A bin width
of 33 cM was decided upon because this was the smallest genetic
interval that gave at least one marker in each bin in every study. In
case there was genetic heterogeneity between the Caucasian and
Chinese Hans populations, we repeated the meta-analysis using
the results from the five Caucasian studies (Nair et al, 1997;
Trembath et al, 1997; Samuelsson et al, 1999; Lee et al, 2000; Veal
et al, 2001). In addition to excluding the Chinese Hans study, we
tested the robustness of our results by excluding one Caucasian
population study at a time and repeating the meta-analysis.
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